Literature DB >> 12920045

Chondroitin sulfate anticoagulant activity is linked to water transfer: relevance to proteoglycan structure in atherosclerosis.

Maria McGee1, William D Wagner.   

Abstract

OBJECTIVE: Changes in chondroitin sulfate (CS) proteoglycan (PG) during atherosclerosis are associated with chronic inflammatory changes and increased incidence of thrombosis. To explore how glycosaminoglycan changes could influence the thrombogenicity of atherosclerotic lesions, water-transfer reactions were examined during activation of antithrombin by CS. METHODS AND
RESULTS: Advanced type IV atherosclerotic lesions prone to thrombosis contained CSPG (versican) with undersulfated CS relative to CS of the adjacent healthy aorta. Approximately 11% of the CS disaccharide in versican from healthy arteries was oversulfated, but this proportion decreased markedly to 3% in atherosclerotic lesions. Oversulfated CS functionally bound antithrombin with a dissociation constant of 3.3+/-1.9 micromol/L. Measured by osmotic stress (OS) techniques with an approximately 26-A probe, the reaction was linked to transfer of approximately 2500 mol water per mole of coagulation factor Xa inhibited. Under OS, the anticoagulant efficiency of CS was 1.3 (micromol/L)(-1) x s(-1), approximately 5- and 15-fold higher than heparan sulfate efficiency measured under OS and standard conditions, respectively.
CONCLUSIONS: Decreased sulfation of high molecular weight CSPG in the advancing atherosclerotic lesions may predispose the lesions to thrombosis by disrupting osmotic regulation, limiting avidity for antithrombin and decreasing activation efficiency.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12920045     DOI: 10.1161/01.ATV.0000090673.96120.67

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  4 in total

1.  Inhibition of antithrombin by Plasmodium falciparum histidine-rich protein II.

Authors:  Matthew Ndonwi; Oname O Burlingame; Aaron S Miller; Douglas M Tollefsen; George J Broze; Daniel E Goldberg
Journal:  Blood       Date:  2011-04-21       Impact factor: 22.113

Review 2.  Versican degradation and vascular disease.

Authors:  Richard D Kenagy; Anna H Plaas; Thomas N Wight
Journal:  Trends Cardiovasc Med       Date:  2006-08       Impact factor: 6.677

Review 3.  A role for proteoglycans in vascular disease.

Authors:  Thomas N Wight
Journal:  Matrix Biol       Date:  2018-02-27       Impact factor: 11.583

4.  A versatile pH sensitive chondroitin sulfate-PEG tissue adhesive and hydrogel.

Authors:  Iossif Strehin; Zayna Nahas; Karun Arora; Thao Nguyen; Jennifer Elisseeff
Journal:  Biomaterials       Date:  2010-01-04       Impact factor: 12.479

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.